The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee recommended liver monitoring at least monthly for women taking ulipristal acetate (Esmya, Gedeon Richter) for uterine fibroids.
News Alerts …read more
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee recommended liver monitoring at least monthly for women taking ulipristal acetate (Esmya, Gedeon Richter) for uterine fibroids.
News Alerts …read more